Several T cell–related therapies are already in the clinic, including checkpoint inhibitors and CAR T cells. Since it allows scientists to precisely edit the genome, CRISPR is a valuable tool for T cell research. With CRISPR technology, T cells can be altered to improve their ability to destroy cancer cells. For best results, start with pure populations of T cells. Invitrogen Dynabeads bead-based kits highly enrich T cell populations without adding contaminants.
Learn more about Dynabeads magnetic separation technology